Dose Matters: The Importance of Appropriate Dosing: A Case Report on Sunitinib Treatment in a Patient With Metastatic Renal Cell Carcinoma

被引：1
|
作者：
Bojic, Marija [1 ]
Schmidinger, Manuela [1 ]
机构：
[1] Med Univ Vienna, A-1090 Vienna, AT, Austria
来源：
CLINICAL GENITOURINARY CANCER | 2012年 / 10卷 / 04期
关键词：
Dosing; Metastatic renal cell carcinoma; Tyrosine kinase inhibitor; INTERFERON-ALPHA; PHASE-3; TRIAL;
D O I：
10.1016/j.clgc.2012.04.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [41] Sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Rini, Brian I.
    Bukowski, Ronald M.
    Curti, Brendan D.
    George, Daniel J.
    Hudes, Gary R.
    Redman, Bruce G.
    Margolin, Kim A.
    Merchan, Jaime R.
    Wilding, George
    Ginsberg, Michelle S.
    Bacik, Jennifer
    Kim, Sindy T.
    Baum, Charles M.
    Michaelson, M. Dror
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2516 - 2524
  • [42] A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
    Morizane, Shuichi
    Iwamoto, Hideto
    Yao, Akihisa
    Isoyama, Tadahiro
    Sejima, Takehiro
    Takenaka, Atsushi
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2012, 65 (04) : 227 - 229
  • [43] Sunitinib in advanced metastatic renal cell carcinoma
    Gonzalez, Diana
    Casado, Gema
    Sierra, Ana
    Tacoronte, Angeles M.
    Herrero, Alicia
    Zamora, Pilar
    Jimenez, Esperanza
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 674 - 674
  • [44] Intolerance to Sunitinib Treatment in Hemodialysis Patients With Metastatic Renal Cell Carcinoma
    Yildiz, Ibrahim
    Sen, Fatma
    Kilic, Leyla
    Ciftci, Rumeysa
    Basaran, Mert
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (01) : 74 - 76
  • [45] Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature
    Daste, Amaury
    Gross-Goupil, Marine
    Quivy, Amandine
    Francois, Louis
    Bernhard, Jean-Christophe
    Ravaud, Alain
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : E525 - E527
  • [46] Drug-induced immune-mediated thrombocytopenia secondary to sunitinib in a patient with metastatic renal cell carcinoma: A case report
    Ansari Z.
    George M.K.
    Journal of Medical Case Reports, 7 (1)
  • [47] Intermittent sunitinib for metastatic renal cell carcinoma
    Venkatesan, Priya
    LANCET ONCOLOGY, 2017, 18 (03): : E139 - E139
  • [48] Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
    Bono, Petri
    Rautiola, Juhana
    Utriainen, Tapio
    Joensuu, Heikki
    ACTA ONCOLOGICA, 2011, 50 (04) : 569 - 573
  • [49] A Case of Acute Adrenal Insufficiency Unmasked During Sunitinib Treatment for Metastatic Renal Cell Carcinoma
    Yoshino, Takayuki
    Kawai, Koji
    Miyazaki, Jun
    Kimura, Tomokazu
    Ikeda, Atsushi
    Takaoka, Ei-ichiro
    Suetomi, Takahiro
    Oikawa, Takehiro
    Kojima, Takahiro
    Iwasaki, Hitoshi
    Shimano, Hitoshi
    Nishiyama, Hiroyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (08) : 764 - 766
  • [50] Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis
    Yoon, Sang Hyun
    Kim, Ki Hyang
    Choi, Junjeong
    Kim, Gun Min
    Kim, Joo Hoon
    Kim, Hyo Song
    Park, Young Nyun
    Rha, Sun Young
    CANCER RESEARCH AND TREATMENT, 2010, 42 (03): : 180 - 184
12345